Signals retweeted
Ontario can boast exciting, innovative and transformational life sciences companies and organizations. Read @LifeSciencesON's Success Stories 2026. CCRM is pleased to be featured again this year. Find us on page 12 and check out #OmniaBio on page 38.
lifesciencesontario.ca/wp-content/upl…
lifesciencesontario.ca/wp-content/upl…
0
3
0
126
How good are you at making predictions? Blogger Cal Strode checks in on some #iPSC predictions made in 2016 as the #stemcell field celebrates 20 years of progress. signalsblog.ca/ipscs-at-20-ho… @ISSCR @KyotoU_News
0
2
1
319
Our resident #optogenetics expert @DrLylaElfay explains its @NobelPrize win and how it has moved beyond #neuroscience signalsblog.ca/a-nobel-for-op…
0
1
1
47
RT @SpichakSimon: Researchers are learning to crack the blood-brain barrier to get drugs more easily into the brain. This has opened doors…
0
8
0
1
Women are most commonly diagnosed with #dysautonomia. What is it & can #stemcells make a difference in treating the improper functioning of the autonomic nervous system? Ellie Kroeger explores the efficacy of treating it with MSCs signalsblog.ca/raising-awaren…
0
1
0
51
A recent #deeptech event in Toronto suggests there is optimism that #quantumcomputing can have a meaningful impact on accelerating the commercialization of cell and gene therapies. Read @msstaceyerin's blog post signalsblog.ca/right-turn-exp… #DeepTechBioLab
1
2
1
110
Signals retweeted
Don't forget to vote for the #CellsISee People's Choice Award by October 7, 2026. #Sciart #contest hosted by CCRM and @StemCellNetwork
Vote here: facebook.com/media/set/?set…
Vote here: facebook.com/media/set/?set…
0
1
0
186
Signals retweeted
A fifth cell and gene therapy product has been approved in the US this year.
Today, the FDA announced approval of an AAV gene therapy developed by ARM member Ultragenyx to treat pediatric patients with Sanfilippo syndrome Type A. 1/2
fda.gov/news-events/pr…
Today, the FDA announced approval of an AAV gene therapy developed by ARM member Ultragenyx to treat pediatric patients with Sanfilippo syndrome Type A. 1/2
fda.gov/news-events/pr…
3
8
17
940
Signals retweeted
Banner week for #DeepTechBioLab: 1st a workshop at @IEEEQuantumWeek & then an event in the @biolabs @UofT space, with presentations & a panel. Want to learn more how we are bringing together #DeepTech companies with #lifesciences? ccrm.ca/deeptech-bio-l… @IonQ_Inc @KausarSamli
0
2
4
3,208
Just as @CBCNews is reporting about doctor #deepfake videos, @msstaceyerin has a timely blog post exploring the topic of who we can trust online with our health: signalsblog.ca/right-turn-hea… Studies from @CaulfieldTim, Megan Munsie, @pewresearch @CMA_Docs
0
3
3
607
Signals retweeted
ICYMI: my call for Japan to do more to stop its huge & growing unproven stem cell/regenerative clinic industry after some deaths and many adverse events ipscell.com/2026/09/amid-p… @ISSCR @ISCTglobal @CaulfieldTim @Signalsblogs
0
6
6
761
Signals retweeted
How do we make CGTs more accessible to patients globally? In the new episode of our podcast, @bambi_grilley & #StaciArnold explore manufacturing & delivery challenges, regulation, P3s & more. Listen where you stream podcasts or at ccrm.ca/podcast. @KristaLambComms
0
2
1
246
📣 Signals is looking for talented bloggers to write about the #regenerativemedicine and #CGT fields. signalsblog.ca
If you’re passionate about cutting-edge science and can turn complex ideas into compelling content, we want to hear from you. DM us to learn more #scicomm
If you’re passionate about cutting-edge science and can turn complex ideas into compelling content, we want to hear from you. DM us to learn more #scicomm
0
2
1
359
Signals retweeted
The 2026 #CellsISee People’s Choice Award voting is now open! "Like" your favourite and the lucky winner will receive $500 at #TMM2026. The #sciart #contest is co-hosted with @StemCellNetwork Vote here: facebook.com/media/set/?van… Pls RT
0
2
4
380
Signals retweeted
🤩 Hope you're excited for our next guest, Dr. Yonatan Stelzer at @WeizmannScience!
The Stelzer Lab investigates how cell fate and identity are established during #embryonic development using single-cell and epigenomic approaches. 🧫
Check out his latest work: bit.ly/3UsGAsB
The Stelzer Lab investigates how cell fate and identity are established during #embryonic development using single-cell and epigenomic approaches. 🧫
Check out his latest work: bit.ly/3UsGAsB
1
4
9
898
Signals retweeted
Inspiring Canada’s next generation of thinkers and problem-solvers starts with empowering educators! Our expanded free, bilingual STEM programming suite gives teachers even more turnkey, Canadian-context tools to bring into their classrooms. Read more:bit.ly/3V0CjaZ
0
2
1
156
Signals retweeted
Scientists stress-tested genes across 22 million human immune cells—using real cells from real donors, not lab models.
Emma Dann & Ronghui Zhu break down why this massive new dataset could reshape cancer immunotherapy and autoimmune treatment.
bit.ly/4xhJxKi
Emma Dann & Ronghui Zhu break down why this massive new dataset could reshape cancer immunotherapy and autoimmune treatment.
bit.ly/4xhJxKi
2
2
4
812
Signals retweeted
The 2026 Cells I See art contest closes today – Fri., Sept. 4! Enter your #sciart now for the chance to win cash prizes. Head to the website for full contest rules, submission instructions and to view past submissions cellsisee.ccrm.ca Pls RT!
0
1
0
168
Signals retweeted
Dr. Lisa Barrett, Professor in the Department of Medicine at Dalhousie University, calls for a bolder immunization future.
The goal is bigger than avoiding infection. It is giving people the freedom to work, learn, create, and live without being derailed by preventable disease.
d by Dr. Barrett alongside Wendy Zatylny, President & CEO of BIOTECanada, with David D. Jones, Managing Director of Merck Canada, guiding the discussion.
Featured in The Future of Life Sciences Expert Series, presented by Merck Canada.
The goal is bigger than avoiding infection. It is giving people the freedom to work, learn, create, and live without being derailed by preventable disease.
d by Dr. Barrett alongside Wendy Zatylny, President & CEO of BIOTECanada, with David D. Jones, Managing Director of Merck Canada, guiding the discussion.
Featured in The Future of Life Sciences Expert Series, presented by Merck Canada.
0
1
0
376





















